Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
about
The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline'Indirect' challenges from science to clinical practicePulmonary function assessment in the early phase of patients with smoke inhalation injury from fireAn open-label study examining the effect of pharmacological treatment on mannitol- and exercise-induced airway hyperresponsiveness in asthmatic children and adolescents with exercise-induced bronchoconstriction.Airway inflammation and mannitol challenge test in COPD.The effect of omega-3 fatty acids on bronchial hyperresponsiveness, sputum eosinophilia, and mast cell mediators in asthma.Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study.Indirect bronchial hyper-responsiveness: the coming of age of a specific group of bronchial challenges.Non-invasive measurement of airway inflammation in asthma.The inflammatory basis of exercise-induced bronchoconstriction.Diagnostic exercise challenge testing.The use of inhaled mannitol in the diagnosis and management of asthma.The usefulness of the mannitol challenge test for asthma.Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide in children with asthma.Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment.Inhaled mannitol as a test for bronchial hyper-responsiveness.Airway response to mannitol challenge in asthmatic children using impulse oscillometry.Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes.Airway responsiveness to mannitol 24 h after allergen challenge in atopic asthmatics.Stability of FeNO and airway hyperresponsiveness to mannitol in untreated asthmatics.
P2860
Q25255964-3B51AE86-8258-4A46-A66C-887D29390BEFQ26767035-5294ADDE-F12D-44AB-BFFE-CC3E5B9B8FC9Q33814686-64602336-3E48-4960-A4EC-7ECD98AC2716Q34062204-AE90CFFE-FC6D-463C-90C7-C7438B7059E0Q34564416-337F61A8-4412-4CFE-B03A-C2E2EBC39B90Q35041503-3F67FD1D-FC8C-4A3C-949A-846B2D49F36DQ35812232-8AE80029-DED9-4C0D-A85B-2CD943858A75Q36077352-39BD2056-99DD-4451-A73D-577AFA619D7AQ36585609-F9CF302C-B578-4F18-9964-DD333A0B07E8Q37819747-AD348C5F-CE38-42F5-B36B-CF7ED6A217E0Q37931726-F8BA3615-3115-44C0-A21F-2787939CC68EQ37961198-181B1641-F2FC-49FE-A0E8-D06852BB39A8Q38162254-CB74515C-ECE3-45BE-8AB9-52A5BB0043C8Q39038543-BACB0D84-0AD5-4E1C-9BF7-F4A8E754F44DQ42401081-6DCADCB9-BEC5-4A04-9A33-AFE38A4D4BDEQ43061633-DFD02072-160C-4DF7-987C-CB2056A5D23FQ43297956-76AE78AE-6C57-458D-ADC8-D7E3A2F045CAQ44232434-5870B089-1469-41FF-A4D4-F350697A8660Q47990933-15BEEED3-C653-4360-B8EE-7F47A797575FQ51450522-1806949B-365E-4915-8082-C97D34B49C51
P2860
Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
@en
Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
@nl
type
label
Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
@en
Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
@nl
prefLabel
Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
@en
Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
@nl
P2860
P1433
P1476
Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
@en
P2093
Heikki Koskela
John D Brannan
P2860
P356
10.1046/J.1440-1843.2002.00357.X
P577
2002-03-01T00:00:00Z